Question 1

How does EquitAI evaluate McGraw Hill, Inc.'s (MH) valuation and Stock DNA?

Accepted Answer

McGraw Hill, Inc. (MH) trades at $13.34 with an EquitAI Valuation DNA score of 5/10 and Quality score of 8/10. The company's trailing P/E ratio is 28.4x. These scores evaluate balance sheet leverage, free cash flow generation, and fundamental multiples against historical benchmarks.

Question 2

What sector and industry does McGraw Hill, Inc. (MH) operate in?

Accepted Answer

McGraw Hill, Inc. (MH) is classified under the Consumer Defensive sector within the Education & Training Services industry. EquitAI benchmarks its fundamental valuation and financial DNA metrics against both direct Education & Training Services peers and broader Consumer Defensive market benchmarks.

Question 3

What is Wall Street's price target and consensus rating for McGraw Hill, Inc. (MH)?

Accepted Answer

Wall Street analysts have a consensus 12-month price target of $16.1 for McGraw Hill, Inc. (MH), representing an implied 21.0% upside from its current trading level of $13.34 with an average rating of Buy based on 3 analyst ratings. Individual analyst price targets range from a low of $14.0 to a high of $17.0, with a median forecast of $16.0. EquitAI benchmarks analyst consensus projections against intrinsic Financial DNA valuation pillars.

Question 4

Does MH pay dividends or capital distributions?

Accepted Answer

McGraw Hill, Inc. does not currently pay a regular dividend yield, prioritizing capital reinvestment into operations, product development, and balance sheet strength.

Question 5

Who are McGraw Hill, Inc.'s (MH) primary market competitors and peers?

Accepted Answer

Key market peers and semantic competitors include WLY, WLYB, PSO, CHGG. EquitAI maps peer relationships through semantic business models, institutional capital flow correlation, and market capitalization weighting.

Question 6

How should investors interpret EquitAI's MH analysis?

Accepted Answer

EquitAI provides quantitative financial research, algorithmic DNA scores, and SEC contextual analytics for informational and research purposes. It does not constitute personalized financial advice or broker-dealer investment recommendations.

MH - McGraw Hill, Inc. Stock Analysis & Valuation

McGraw Hill, Inc.

FIT ANALYSIS